Peers for comparison


Market capitalization
‪114.03 M‬ USDMicro cap
−0.31 USD
‪−10.93 M‬ USD
0.00 USD
‪32.81 M‬
Beta (1Y)
0.97
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Employees (FY)
4
Change (1Y)
−1−20.00%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−2.73 M‬ USD

Company info


CEO
Amit D. Kumar
Website
Headquarters
San Jose
Founded
1982
IPO date
Oct 7, 1983
ISIN
US03528H1095
CUSIP
03528H109
FIGI
BBG000BG3J79
Identifiers
ISIN US03528H1095
CFI code
ESVUFR
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


Anixa Biosciences, Inc. is scheduled to release its next earnings report on Jan 6, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
ANIX stock is 6.35% volatile and has beta coefficient of 0.97.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like ANIX are typically less volatile than smaller companies

Track every detail on Anixa Biosciences, Inc. stock chart and check out the list of the most volatile stocks — is Anixa Biosciences, Inc. there?
To understand the ANIX stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +4.79%
– 1 week — −3.20%
– 1 month — +5.48%

ANIX all-time low was 0.60 USD (Aug 15, 2017), and its highest price is 259.38 USD (Jul 7, 1993). Find more dynamics in the Stock Heatmap and on the Anixa Biosciences, Inc. stock chart.
Anixa Biosciences, Inc. market capitalization is ‪114.03 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Anixa Biosciences, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Anixa Biosciences, Inc. stacks up against other companies
The safest way to buy Anixa Biosciences, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade ANIX directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 8, 2026, the company has 4 employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Investing in Anixa Biosciences, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Anixa Biosciences, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our ANIX technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — neutral

Combine fundamental and technical analysis for better results.
Anixa Biosciences, Inc. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Anixa Biosciences, Inc. stocks trade under the symbol ANIX.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
ANIX earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.08 USD, resulting in a 2.20% surprise. The estimated earnings for the next quarter are −0.08 USD per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in Anixa Biosciences, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Anixa Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.

What it might mean:
– Stable demand: Sales are holding steady without clear growth or decline
– Mature business phase: Growth may be slowing in core segments
– Offsetting factors: Strength in some areas may be balancing weakness in others

What to look at next in Anixa Biosciences, Inc. financials:
– Margins: Profitability may improve or decline even if revenue is flat
– Net income & EPS: Cost control or share buybacks can still drive earnings changes
– Segment breakdown: Some business lines may be growing while others shrink
Yes, you can track Anixa Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
ANIX net income for the last quarter is ‪−2.61 M‬ USD, while the quarter before that showed ‪−2.52 M‬ USD of net income which accounts for −3.58% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Anixa Biosciences, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Anixa Biosciences, Inc. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
ANIX reached its all-time high of 259.38 USD on Jul 7, 1993. Its all-time low was 0.60 USD and was reached on Aug 15, 2017.

Explore the Anixa Biosciences, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Analyst forecasts suggest a price range between 6.00 USD and 14.00 USD for ANIX, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance